TEAS RF New Application

VERTEX GENETIC THERAPIES

Vertex Pharmaceuticals Incorporated

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88578476
Filing Date: 08/14/2019

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88578476
MARK INFORMATION
*MARK VERTEX GENETIC THERAPIES
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT VERTEX GENETIC THERAPIES
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Vertex Pharmaceuticals Incorporated
*STREET 50 Northern Avenue
*CITY Boston
*STATE
(Required for U.S. applicants)
Massachusetts
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
02210
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY OF INCORPORATION Massachusetts
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION house mark for pharmaceutical preparations; nucleic acid medicines; pharmaceutical preparations for the treatment of genetic diseases and disorders; pharmaceutical preparations for the treatment of muscular dystrophy
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 042 
*IDENTIFICATION medical and scientific research in the field of gene therapy; medical and scientific research in the field of nucleic acid; gene editing for developing cells and pharmaceuticals for medical and clinical use; research and development of pharmaceuticals using gene editing
FILING BASIS SECTION 1(b)
ADDITIONAL STATEMENTS SECTION
ACTIVE PRIOR REGISTRATION(S) The applicant claims ownership of active prior U.S. Registration Number(s) 1630448, 2704913, 3531356, and others.
ATTORNEY INFORMATION
NAME Steven A. Abreu
ATTORNEY DOCKET NUMBER 1618/2107
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Sunstein Kann Murphy & Timbers LLP
STREET 125 Summer Street
CITY Boston
STATE Massachusetts
COUNTRY United States
ZIP/POSTAL CODE 02110
PHONE 617-443-9292
FAX 6174430004
EMAIL ADDRESS trademarks@sunsteinlaw.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY Kerry Timbers; Lisa Tittemore; Joel Leeman; Steve Abreu; Sharona Sternberg; Lena Cavallo; Erin Connors
CORRESPONDENCE INFORMATION
NAME Steven A. Abreu
FIRM NAME Sunstein Kann Murphy & Timbers LLP
STREET 125 Summer Street
CITY Boston
STATE Massachusetts
COUNTRY United States
ZIP/POSTAL CODE 02110
PHONE 617-443-9292
FAX 6174430004
*EMAIL ADDRESS trademarks@sunsteinlaw.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS RF
NUMBER OF CLASSES 2
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEE DUE 550
*TOTAL FEE PAID 550
SIGNATURE INFORMATION
SIGNATURE /Kerry Flynn/
SIGNATORY'S NAME Kerry Flynn
SIGNATORY'S POSITION Vice President, Chief IP Counsel
SIGNATORY'S PHONE NUMBER 6179617117
DATE SIGNED 08/14/2019



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88578476
Filing Date: 08/14/2019

To the Commissioner for Trademarks:

MARK: VERTEX GENETIC THERAPIES (Standard Characters, see mark)
The literal element of the mark consists of VERTEX GENETIC THERAPIES. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Vertex Pharmaceuticals Incorporated, a corporation of Massachusetts, having an address of
      50 Northern Avenue
      Boston, Massachusetts 02210
      United States

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  house mark for pharmaceutical preparations; nucleic acid medicines; pharmaceutical preparations for the treatment of genetic diseases and disorders; pharmaceutical preparations for the treatment of muscular dystrophy
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 042:  medical and scientific research in the field of gene therapy; medical and scientific research in the field of nucleic acid; gene editing for developing cells and pharmaceuticals for medical and clinical use; research and development of pharmaceuticals using gene editing
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.


Claim of Active Prior Registration(s)
The applicant claims ownership of active prior U.S. Registration Number(s) 1630448, 2704913, 3531356, and others.


The applicant hereby appoints Steven A. Abreu. Other appointed attorneys are Kerry Timbers; Lisa Tittemore; Joel Leeman; Steve Abreu; Sharona Sternberg; Lena Cavallo; Erin Connors. Steven A. Abreu of Sunstein Kann Murphy & Timbers LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      125 Summer Street
      Boston, Massachusetts 02110
      United States
      617-443-9292(phone)
      6174430004(fax)
      trademarks@sunsteinlaw.com (authorized).
The attorney docket/reference number is 1618/2107.
Steven A. Abreu submitted the following statement: I attest that I am an attorney who is an active member in good standing of the bar of the highest court of a U.S. state (including the District of Columbia and any U.S. Commonwealth or territory).

The applicant's current Correspondence Information:
      Steven A. Abreu
      Sunstein Kann Murphy & Timbers LLP
      125 Summer Street
      Boston, Massachusetts 02110
      617-443-9292(phone)
      6174430004(fax)
      trademarks@sunsteinlaw.com (authorized).

Email Authorization: I authorize the USPTO to send email correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the email address provided in this application. I understand that a valid email address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $550 has been submitted with the application, representing payment for 2 class(es).

Declaration

Declaration Signature

Signature: /Kerry Flynn/   Date: 08/14/2019
Signatory's Name: Kerry Flynn
Signatory's Position: Vice President, Chief IP Counsel
Payment Sale Number: 88578476
Payment Accounting Date: 08/14/2019

Serial Number: 88578476
Internet Transmission Date: Wed Aug 14 13:57:31 EDT 2019
TEAS Stamp: USPTO/BAS-XX.XX.XX.XX-201908141357314307
82-88578476-610c077c8f12feedd6be394c2bd8
1b2bd33e062ac71f91411b9735a92716d3a923-D
A-57314166-20190814115437036953

TEAS RF New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed